Trial Profile
A Double-Blind Study of Lamictal [lamotrigine] in Neurotic Excoriation.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Nov 2019
Price :
$35
*
At a glance
- Drugs Lamotrigine (Primary)
- Indications Impulse control disorders
- Focus Therapeutic Use
- 01 Aug 2010 Results have been published in the Journal of Clinical Psycopharmacology.
- 26 Mar 2010 Actual patient number (35) added as reported by ClinicalTrials.gov.
- 26 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.